University at Buffalo (UB)
Andrei Gudkov, PhD, DSc, "NAMPT Inhibitor OT-82 targeting energy metabolism in hematologic malignancies"
Organized by the UB Clinical and Translational Science Institute Drug Development Core, this series presents:
- Case studies in drug discovery and pre-clinical development
- Opportunities to become familiar with GLP and pre-clinical drug development programs
- Regulatory compliance leading to IND application
- Strategies for translation to Phase I study design
Kelly Patton
Email: kepatton@buffalo.edu